TrialArthritis & rheumatology (Hoboken, N.J.)2016

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Treatment With Sirukumab (CNTO 136) in Patients With Active Lupus Nephritis.

Brad H Rovin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.